Newsmeme!
Discover News you didn't know existed
Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.
Patients who had first period before age 12 are at increased risk of death, study shows
Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles. This finding suggests that hormonal activity over the course of a woman's lifetime may influence the prognosis after an ovarian cancer diagnosis.
THURSDAY, July 9 (HealthDay News) -- Among women with ovarian cancer, those who had their first menstrual period before the age of 12 and who had the most menstrual cycles over a lifetime are more likely to die of the cancer than those who had fewer ovulatory cycles, a new study shows.
GREATER AKRON — OB/GYN Associates has served women in the Greater Akron community for more than 35 years with experience and numerous awards of excellence.
1) Greater number of lifetime ovulations linked to higher risk of death; 2) Earlier age of menarche increases risk of death.
( American Association for Cancer Research ) Researchers from the US Centers for Disease Control and Prevention found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.
• Greater number of lifetime ovulations linked to higher risk of death • Earlier age of menarche increases risk of death
Hologic, Inc., (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced the U.S. Food and Drug Administration (FDA) has approved the Company's premarket approval (PMA) application for the Adiana(R) permanent contraception system.
Hologic Inc., the Bedford-based women’s health care company, has won approval from the federal Food and Drug Administration (FDA) to sell its Adiana permanent contraception system.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |